Seattle Genetics | Zobowiązania Handlowe



Trade Creditors Zmiana Data
AbbVie 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Amgen USD 2.41B 498M 2025-03
Astellas Pharma JPY 187.84B 16.46B 2025-03
Bayer EUR 6.59B 931M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Celldex Therapeutics USD 3.41M 145K 2025-03
Daiichi Sankyo JPY 564.47B 61.64B 2024-12
Eisai JPY 91.57B 27.04B 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Exelixis USD 42.84M 4.65M 2025-04
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 195.54M 1.93M 2025-03
Insmed USD 61.4M 15.82M 2025-03
MacroGenics USD 5.01M 1.6M 2024-12
Merck USD 3.78B 295M 2025-03
Moderna USD 226M 179M 2025-03
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.24B 393M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Sanofi 21.62B 14.07B 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Takeda JPY 475.54B 15.36B 2025-03
Teva Pharmaceutical Industries USD 2.29B 87M 2025-03
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Xencor USD 16.19M 568K 2025-03



Seattle Genetics Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.